Suppr超能文献

miRNAs 的综合分析确定了头颈鳞状细胞癌中具有临床相关性的上皮和基质亚型。

Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell Carcinoma.

机构信息

Division of Hematology and Oncology, Department of Medicine, Center for Cancer Research, University of Tennessee Health Science Center, Memphis, Tennessee.

Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania.

出版信息

Clin Cancer Res. 2021 Feb 1;27(3):831-842. doi: 10.1158/1078-0432.CCR-20-0557. Epub 2020 Nov 4.

Abstract

PURPOSE

The objective of this study is to characterize the role of miRNAs in the classification of head and neck squamous cell carcinoma (HNSCC).

EXPERIMENTAL DESIGN

Here, we analyzed 562 HNSCC samples, 88 from a novel cohort and 474 from The Cancer Genome Atlas, using miRNA microarray and miRNA sequencing, respectively. Using an integrative correlations method followed by miRNA expression-based hierarchical clustering, we validated miRNA clusters across cohorts. Evaluation of clusters by logistic regression and gene ontology approaches revealed subtype-based clinical and biological characteristics.

RESULTS

We identified two independently validated and statistically significant ( < 0.01) tumor subtypes and named them "epithelial" and "stromal" based on associations with functional target gene ontology relating to differing stages of epithelial cell differentiation. miRNA-based subtypes were correlated with individual gene expression targets based on miRNA seed sequences, as well as with miRNA families and clusters including the miR-17 and miR-200 families. These correlated genes defined pathways relevant to normal squamous cell function and pathophysiology. miRNA clusters statistically associated with differential mutation patterns including higher proportions of mutations in the stromal class and higher and mutation frequencies in the epithelial class. miRNA classes correlated with previously reported gene expression subtypes, clinical characteristics, and clinical outcomes in a multivariate Cox proportional hazards model with stromal patients demonstrating worse prognoses (HR, 1.5646; = 0.006).

CONCLUSIONS

We report a reproducible classification of HNSCC based on miRNA that associates with known pathologically altered pathways and mutations of squamous tumors and is clinically relevant.

摘要

目的

本研究旨在探讨 miRNA 在头颈部鳞状细胞癌(HNSCC)分类中的作用。

实验设计

我们分别使用 miRNA 微阵列和 miRNA 测序分析了 562 例 HNSCC 样本,其中 88 例来自新队列,474 例来自癌症基因组图谱。采用整合相关方法结合基于 miRNA 表达的层次聚类,我们验证了队列间的 miRNA 簇。通过逻辑回归和基因本体分析评估聚类,揭示了基于亚型的临床和生物学特征。

结果

我们确定了两个独立验证且具有统计学意义的(<0.01)肿瘤亚型,并根据与上皮细胞分化不同阶段相关的功能靶基因本体论的关联,将其命名为“上皮”和“基质”。基于 miRNA 种子序列的单个基因表达靶标、miRNA 家族和簇(包括 miR-17 和 miR-200 家族),miRNA 亚型与个体基因表达靶标相关。这些相关基因定义了与正常鳞状细胞功能和病理生理学相关的途径。miRNA 簇与差异突变模式统计学相关,包括基质类中更高比例的突变和上皮类中更高的突变和突变频率。miRNA 类与先前报道的基因表达亚型、临床特征和多变量 Cox 比例风险模型中的临床结果相关,其中基质患者的预后更差(HR,1.5646;=0.006)。

结论

我们报告了一种基于 miRNA 的 HNSCC 可重现分类,其与已知的病理改变途径和鳞状肿瘤的突变相关,并且具有临床相关性。

相似文献

引用本文的文献

本文引用的文献

3
COSMIC: the Catalogue Of Somatic Mutations In Cancer.COSMIC:癌症体细胞突变目录。
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947. doi: 10.1093/nar/gky1015.
4
8
MicroRNAs and cancer: Key paradigms in molecular therapy.微小RNA与癌症:分子治疗的关键范例
Oncol Lett. 2018 Mar;15(3):2735-2742. doi: 10.3892/ol.2017.7638. Epub 2017 Dec 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验